Northwest Arkansas Clinical Trials Center

Rogers, Arkansas 72758

1 studies enrolling now · 14 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Axillary Hyperhidrosis, Dermatitis, Atopic, Gorlin Syndrome, Hidradenitis Suppurativa, Plaque Psoriasis, Primary Axillary Hyperhidrosis

Studies at this site

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo — Recruiting now
• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome — Running, not enrolling
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis — Completed
• Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis — Completed
• A Study of LY3041658 in Adults With Hidradenitis Suppurativa — Completed
• A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis — Completed
• A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis — Completed
• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed